Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAIA study of antipsychotic exposure during pregnancy in severe mental illness
NL-OMON56645Recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2024
- Countries
- 1
01
Overview
Open-label trial in bipolar disorder (BD) and Schizophrenia Spectrum Disorders (SSD) (4 arms), sponsored by Erasmus MC. Primary endpoint: Relapse with mood or psychotic episode during the peripartum period. Started Mar 2024; status: recruiting.
02
Conditions
bipolar disorder (BD)Schizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on NL-OMON56645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56645.